TFF2 and infection: At baseline visit between July 2020 and January 2021, when no vaccination was available, 34 of 367 (9.3%) participants had a history of infection with SARS-CoV-2 as demonstrated by a positive PCR or antigenic test and/or positive serological test for anti-SP (Table 1 and Fig. 2).